Total Funding
13
Total FundingSeries D raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Thrasos discovers and develops targeted therapies for the prevention and treatment of severe organ failures.
Philippe Bey: Senior Vice President, Research and Development- Jerome Rossert: Chief Scientific Officer, Chief Medical Officer
About the Company
Thrasos is a bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company's lead therapeutic program, THR-184, is focused on the prevention and treatment of acute kidney injury (AKI). The Company also has a
preclinical development program for treating chronic kidney disease (CKD).
